NASDAQ:ONCY
Oncolytics Biotech Inc. Stock News
$1.11
-0.0200 (-1.77%)
At Close: May 17, 2024
Moderna COVID-19 vaccine data is ‘baby-step’ in right direction: Expert
06:47pm, Monday, 18'th May 2020
Professor of Medicine at Yale and Director of The Yale New Haven Hospital Center for Outcomes Research and Evaluation Dr. Harlan Krumholz joins Yahoo Finance’s Seana Smith to discuss Moderna’s rec
The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows
12:00am, Sunday, 17'th May 2020
Biotech stocks had another up week, with the American Society of Gene & Stem Cell Therapy virtual conference presentations and the ASCO abstracts made available online ...
Oncolytics Biotech® Announces Publication of Abstracts at the 2020 American Society of Clinical Oncology Virtual Annual Meeting
11:00am, Thursday, 14'th May 2020
Oncolytics Biotech® Announces Publication of Abstracts at the 2020 American Society of Clinical Oncology Virtual Annual Meeting
Oncolytics Biotech® to Present at the RBC Global Healthcare Conference
11:00am, Wednesday, 13'th May 2020
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced that Matt Coffey, President & CEO of Oncolytics
3 Biotech Stocks Under $3 With 200%-Plus Upside Potential
02:38pm, Tuesday, 12'th May 2020
The healthcare sector took its place among the winners this year, rising 11%, compared to the S&P; 500’s 9% drop. The bottom-line for investors? Wall Street’s focus is on the healthcare space, loc
RBC Capital Maintains Outperform on Oncolytics Biotech, Lowers Price Target to $6
12:00am, Monday, 11'th May 2020Oncolytics Biotech® Reports 2020 First Quarter Financial Results and Operational Highlights
11:00am, Friday, 08'th May 2020
SAN DIEGO and CALGARY, Alberta , May 8, 2020 /CNW/ -- Oncolytics Biotech® Inc. (ONCY) (ONC.TO), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today annou
Stocks surge as more states move to reopen amid coronavirus
07:11pm, Tuesday, 05'th May 2020
JP Morgan Private Bank Head of Cross-Asset Thematic Strategy Anastasia Amoroso joins Yahoo Finance’s Seana Smith to discuss the latest market action as more states move to reopen their economies in
Oncolytics Biotech® to Present Clinical Findings of Pelareorep-Induced Immune Response in Breast Tumors at the ESMO Breast Cancer Virtual Meeting
Oncolytics Biotech (NASDAQ:ONCY) Upgraded to "Buy" at ValuEngine
06:24am, Saturday, 02'nd May 2020
Oncolytics Biotech (NASDAQ:ONCY) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a report released on Friday, ValuEngine reports. A number of other equities analysts also
Oncolytics Biotech® Announces Changes to Annual General Meeting
11:00am, Thursday, 30'th Apr 2020
SAN DIEGO and CALGARY, Alberta , April 30, 2020 /CNW/ -- Oncolytics Biotech ® Inc. (ONCY) (ONC.TO), (the "Company") today announced that in light of the ongoing COVID-19 pandemic, it is taking
